Coming Off Semaglutide Without the Weight Coming Back
Most people regain weight after stopping, and the trials show how much. Here is why it happens, what a planned step-down looks like, and the habits that do the heavy lifting.
ALTRcare Medical Team
Clinical Editorial
For most people, some or all of the weight comes back after stopping semaglutide. In the STEP 1 trial extension, people who stopped both the medicine and the lifestyle programme regained about two-thirds of the weight they had lost within a year. The risk is lower, though not zero, when stopping is planned: the dose comes down in steps over several months, protein, strength work and a daily eating routine are firmly in place, and a doctor watches the scale and steps in early if weight starts to climb.
Key facts
- One year after stopping semaglutide and the trial's lifestyle programme, participants had regained about two-thirds of their earlier weight loss (STEP 1 extension, Diabetes Obes Metab 2022).
- In STEP 4, people who kept taking semaglutide lost a further 7.9% of body weight over 48 weeks, while those switched to placebo regained 6.9% (Rubino et al., JAMA 2021).
- Tirzepatide shows the same pattern: after switching to placebo, body weight rose by 14.0% in a year, against a further 5.5% loss on continued treatment (SURMOUNT-4, JAMA 2024).
- Semaglutide stays in the blood for about 5 to 7 weeks after the last injection, so appetite returns gradually, not overnight (US prescribing information).
- The American Diabetes Association advises continuing obesity medicine beyond the weight-loss goal, because stopping often brings the weight back (ADA Standards of Care 2026).
What the trials actually show
Three trials answer the question directly, and they agree.
| Trial | What they did | What happened |
|---|---|---|
| STEP 1 extension (semaglutide) | Stopped the medicine and the lifestyle programme after 68 weeks, then followed for a year | Regained about two-thirds of the lost weight; still 5.6% below where they started, on average |
| STEP 4 (semaglutide) | After 20 weeks on treatment, half switched to placebo for 48 weeks | Continued: a further 7.9% loss. Placebo: 6.9% regained |
| SURMOUNT-4 (tirzepatide) | After 36 weeks on treatment, half switched to placebo for a year | Continued: a further 5.5% loss. Placebo: body weight up 14.0%; only 16.6% kept most of their loss |
Two details matter. First, the STEP 1 extension stopped the lifestyle programme along with the medicine, so participants lost their support and their medicine at the same moment. Second, even after regaining two-thirds, they were on average still lighter than when they began. Stopping is not the same as never having started. The trial's authors concluded that obesity is a chronic condition and that ongoing treatment is needed to keep the improvements (full text).
Why the weight comes back
Semaglutide works by turning down hunger and slowing the stomach. When it leaves the body over five to seven weeks, those signals return. The body also fights to regain lost weight: after weight loss, hunger tends to rise and the body burns a little less energy than before. None of this is a failure of willpower. It is biology, and it is the reason a plan for stopping has to be made before the last dose, not after the weight returns. Our guide to why hunger comes back explains the hormones in more detail.
What a planned step-down looks like
There is an honest caveat first. As of late 2026 we are not aware of a large randomised trial that tests a slow step-down against stopping all at once. A gradual taper is a careful way to stop, chosen by many doctors, but it is not proven to prevent regain. What the evidence does support is everything around it: keeping muscle, eating enough protein, staying active and catching regain early.
- 1
Before the last full dose
Decide together, and set your number
Your doctor agrees the plan with you and sets a clear trigger, for example a set number of kilos above your current weight, at which you both review the plan.
- 2
Months 1 to 2
The dose comes down in steps
Your doctor lowers the dose step by step and watches how your hunger and weight respond. Never change your own dose; the steps are set at your consultation.
- 3
Months 1 to 4
Protein, strength and structure
Protein at every meal, two or three strength sessions a week, a walk after dinner, and a weekly eating plan on WhatsApp built around what your family cooks.
- 4
Every month
The same doctor, every follow-up
A consultation each month with the doctor who started your treatment, so someone who knows your history sees the trend early.
- 5
Month 3 to 4, and after
Off, or a low dose that holds
Some people come off completely. Some hold a low dose long term, as they would a blood pressure tablet. Both are reasonable. The decision is made on your numbers, not on a fixed date.
This is how ALTRcare's 3 to 4 month maintenance phase works.
The habits that do the heavy lifting
- Protein at every meal. Dal, paneer, curd, chana, soya, eggs, chicken or fish. It helps keep the muscle you have, and muscle helps keep the weight off. Vegetarian? See how to reach 70 g a day without eggs.
- Strength training. Two or three short sessions a week, at home with bands or bodyweight is fine. Walking alone does not protect muscle as well.
- A fixed eating rhythm. Three meals and one planned snack, at roughly the same times. The old habit of grazing is where regain usually starts.
- Weigh weekly, same day, same scale. A weekly number catches a slow climb; a daily one mostly shows water.
- Plan for the hard weeks. Diwali, weddings and travel are where most regain begins. Tell your doctor or nutritionist in advance, and plan the week rather than hoping for the best.
If the weight starts to come back
Regain is information, not failure. If your weight passes the agreed trigger, your doctor reviews what has changed. Often a tighter eating plan is enough. Sometimes restarting the medicine is the right call. If you restart after a gap, do not go straight back to your old dose: the label advises restarting at a lower dose after two or more missed weeks, to avoid stomach side effects (US prescribing information). Your doctor sets the dose.
Planning ahead matters
Whether you are starting or thinking about stopping, a doctor who knows your history makes the decision safer. Start with a 2-minute eligibility check.
Frequently asked questions
Will I regain weight after stopping semaglutide?
Most people regain some or all of it. In the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year of stopping both the medicine and the lifestyle programme, though on average they stayed below their starting weight. A planned step-down with strong habits and regular follow-up lowers the risk.
Should I stop semaglutide suddenly or taper off?
Plan it with your doctor rather than stopping on your own. Many doctors lower the dose in steps while watching weight and hunger. No large trial has yet proved that tapering prevents regain, but it gives you and your doctor time to catch a climb early.
How long after stopping does hunger come back?
Semaglutide stays in the blood for about 5 to 7 weeks after the last injection, so appetite usually returns gradually over the following weeks rather than overnight.
Can I restart semaglutide if the weight comes back?
Yes, if your doctor agrees. After a gap of two or more weeks, the label advises restarting at a lower dose and stepping up again to reduce stomach side effects. Do not restart at your old dose on your own.
Do I have to take semaglutide forever?
Not necessarily. Some people stay on a low maintenance dose long term, as guidelines suggest for many, and some come off with a planned step-down. The right choice depends on your health, your weight trend and what you can sustain, and it is made with your doctor.
Medically reviewed by
MBBS, MD, DM (Endocrinology)Reg. No. 71516, Telangana State Medical Council
Dr. Mujeeb Afzal is a consultant endocrinologist (MBBS, MD, DM Endocrinology) on ALTRcare's senior medical team. He sees patients whose weight is tied up with hormones, thyroid disease, diabetes or PCOS, and reviews ALTRcare's clinical protocols for GLP-1 medicines.
Last reviewed 28 October 2026 · How we review our guides
Sources
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension (Diabetes, Obesity and Metabolism, 19 May 2022)
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4) (JAMA, 13 April 2021)
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4) (JAMA, 2 January 2024)
- 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes 2026 (Diabetes Care (American Diabetes Association), 1 January 2026)
- WEGOVY (semaglutide) injection, US prescribing information (revised June 2026) (DailyMed, US National Library of Medicine)
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed, with no obligation.
Free PDF guide
Your 3-month semaglutide plan, in seven pages
- How semaglutide works and the 0.25 mg → 0.5 mg → 1 mg dose steps
- Everything in the plan, Standard vs Premium, from ₹10,999 (₹3,666 a month)
- What results look like, from the trials and from ALTRcare patients
- Your four doctors, and what happens after month 3
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
